Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pour

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Vnitrni Lekarstvi|May 29, 2013
[PET-CT documented fast onset of treatment response to cyclophosphamide, thalidomide and dexamethasone in patients with multicentric Castlemans disease. Case description and treatment information overview]Z Adam, P Szturz, L Křen, et al.
Neoplasma|February 21, 2019
Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal GammopathiesV Maisnar, Z Stefanikova, I Spicka, et al.
Vnitrni Lekarstvi|March 28, 2012
[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation]Z Adam, Z Rehák, R Koukalová, et al.
Vnitrni Lekarstvi|April 8, 2009
[Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation]Z Adam, K Veselý, M Krejcí, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 16, 2009
[The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells]D Ocadlíková, L Zahradová, L Kovárová, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 19, 2026
Polyclonal hypergammaglobulinemia, infiltration of the salivary glands, lymphadenopathy, and kidney damage - Mikulicz's disease, Sjögren's syndrome, or Castleman's disease? Case report and overview of differential diagnosis and treatmentZ Adam, Z Fojtík, Z Řehák, et al.
Vnitrni Lekarstvi|April 3, 2012
[Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide]Z Adam, L Pour, M Matýšková, et al.
Vnitrni Lekarstvi|March 25, 2010
[Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review]Z Adam, K Balsíková, M Krejcí, et al.
Neoplasma|January 27, 2010
Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantationH Greslikova, R Zaoralova, H Filkova, et al.
Neoplasma|September 8, 2011
Prognostic significance of morphological assessment of plasma cells in multiple myelomaM Al-Sahmani, I Trnavska, S Sevcikova, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Vnitrni Lekarstvi|May 29, 2013
[PET-CT documented fast onset of treatment response to cyclophosphamide, thalidomide and dexamethasone in patients with multicentric Castlemans disease. Case description and treatment information overview]Z Adam, P Szturz, L Křen, et al.
Neoplasma|February 21, 2019
Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal GammopathiesV Maisnar, Z Stefanikova, I Spicka, et al.
Vnitrni Lekarstvi|March 28, 2012
[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation]Z Adam, Z Rehák, R Koukalová, et al.
Vnitrni Lekarstvi|April 8, 2009
[Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation]Z Adam, K Veselý, M Krejcí, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 16, 2009
[The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells]D Ocadlíková, L Zahradová, L Kovárová, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 19, 2026
Polyclonal hypergammaglobulinemia, infiltration of the salivary glands, lymphadenopathy, and kidney damage - Mikulicz's disease, Sjögren's syndrome, or Castleman's disease? Case report and overview of differential diagnosis and treatmentZ Adam, Z Fojtík, Z Řehák, et al.
Vnitrni Lekarstvi|April 3, 2012
[Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide]Z Adam, L Pour, M Matýšková, et al.
Vnitrni Lekarstvi|March 25, 2010
[Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review]Z Adam, K Balsíková, M Krejcí, et al.
Neoplasma|January 27, 2010
Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantationH Greslikova, R Zaoralova, H Filkova, et al.
Neoplasma|September 8, 2011
Prognostic significance of morphological assessment of plasma cells in multiple myelomaM Al-Sahmani, I Trnavska, S Sevcikova, et al.
Pageof 11